Therapy News and Research

RSS

Mirixa integrates with PrescribeWellness

Mirixa Corporation, the leading provider of Medication Therapy Management (MTM) and other pharmacist-delivered patient care services for health plans, announces their integration with PrescribeWellness, the SaaS Company with a cloud-based platform that delivers efficient patient communications and other services to community pharmacists.

19 Feb 2015

Advances in stem cell therapy can improve outcomes for patients with chronic diabetic foot ulcers

According to data presented at the 73rd Annual Scientific Conference of the American College of Foot and Ankle Surgeons, advances in stem cell therapy can significantly improve outcomes for patients with chronic diabetic foot ulcers. Use of stem cells to treat foot problems like diabetic ulcers may speed up the healing process, preventing infection and hospitalization during recovery.

19 Feb 2015

Regulus Therapeutics reports net loss of $22.2 million for fourth quarter 2014

Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today reported financial results for the fourth quarter and year ended December 31, 2014, including a summary of recent corporate highlights.

19 Feb 2015

Epic Health Services acquires Loving Care Agency

Epic Health Services Inc., a portfolio company of Webster Capital and Dallas-based provider of pediatric skilled nursing and therapy, announced today the completion of its acquisition of the parent company and pediatric division of Loving Care Agency, Inc., a provider of pediatric and adult home health care services based in Hasbrouck Heights, New Jersey.

19 Feb 2015

Scientists identify potential target to combat leishmaniasis

Research led by St. Jude Children's Research Hospital scientists has identified a potential target in the quest to develop a more effective treatment for leishmaniasis, a parasitic tropical disease that kills thousands and sickens more than 1 million people worldwide each year.

19 Feb 2015

TE Connectivity signs definitive agreement to acquire AdvancedCath

TE Connectivity Ltd., a world leader in connectivity, announced today that it has entered into a definitive agreement to acquire AdvancedCath for $190 million USD in cash.

19 Feb 2015

TDF monotherapy ‘reasonable’ option in entecavir-resistant HBV

Researchers from the Republic of Korea have found that the efficacy of tenofovir disoproxil fumarate monotherapy is comparable to that of TDF plus entecavir in chronic hepatitis B patients with genotypic resistance to entecavir.

18 Feb 2015

Long-term TDF ‘promising’ in Chinese HBV patients after multiple antiviral failures

Long-term tenofovir disoproxil fumarate therapy is effective in Chinese patients with chronic hepatitis B virus infection who have relapsed after treatment with multiple nucleos(t)ide analogues, research suggests.

18 Feb 2015

Facts about precision medicine

President Barack Obama is requesting an increase of $215 million in the 2016 federal budget to launch the Precision Medicine Initiative. This boost in funding for research will give genetic causes of cancer a national focus specifically around precision or "personalized" treatments for cancer in the future.

18 Feb 2015

Caris Life Sciences announces record-setting revenue for 2014

Caris Life Sciences, a leading biosciences company focused on fulfilling the promise of precision medicine, today announced select year-end financial and operational results for 2014, which include record-setting revenue and continued case volume growth for its panomic, comprehensive tumor profiling service, Caris Molecular Intelligence.

18 Feb 2015

Oncolytics announces completion of patient enrollment in REOLYSIN Phase II colorectal cancer study

Oncolytics Biotech Inc. today announced that enrollment has been completed in a randomized Phase II study of REOLYSIN in patients with advanced or metastatic colorectal cancer (IND 210). The trial is being sponsored and conducted by the NCIC Clinical Trials Group at Queen's University in Kingston, Ontario.

18 Feb 2015

Researchers show importance of DNA damage in fine tuning of innate immune system

For the first time scientists from Umeå University show the importance of DNA damage in fine tuning of our innate immune system and hence the ability to mount the optimal inflammatory response to infections and other biological dangers.

18 Feb 2015

CTCA presents research on new cancer nutrition therapies at A.S.P.E.N. Clinical Nutrition Week

Several Cancer Treatment Centers of America clinicians presented research from studies evaluating new cancer nutrition techniques and therapies at the American Society for Parenteral and Enteral Nutrition Clinical Nutrition Week held in Long Beach, Calif., February 14-17, 2015. CTCA clinicians led a plenary session and an oral abstract presentation, and presented eight posters to Clinical Nutrition Week attendees.

18 Feb 2015

SLU researchers halt fatty liver disease in animal model

Doctors believe that up to 30 percent of the U.S. population may have fat accumulation in the liver, known as non-alcoholic fatty liver disease (NAFLD), that can lead to a range of damaging health consequences.

18 Feb 2015

Eliglustat drug improves liver, spleen size and hemoglobin level in adults with Gaucher disease type 1

Among previously untreated adults with Gaucher disease type 1, a genetic disease in which there is improper metabolism due to a defect in an enzyme, treatment with the drug eliglustat resulted in significant improvements in liver and spleen size hemoglobin level, and platelet count, according to a study in the February 17 issue of JAMA.

18 Feb 2015

$Postmenopausal women susceptible to bone fractures may be at increased risk for gum disease$

Postmenopausal women susceptible to bone fractures may be at increased risk for gum disease

Postmenopausal women susceptible to bone fractures may also be a higher risk for gum disease, according to researchers at Case Western Reserve University School of Dental Medicine and Case/Cleveland Clinic Postmenopausal Health Collaboration.

18 Feb 2015

Organizational culture may increase use of evidence-based treatments for adolescents with psychiatric disorders

Many mental health therapists use treatments that have little evidence to support them. A new multi-institution study led by Penn Medicine has found that an organization's culture and climate are better predictors of the use of evidence-based practices than an individual therapist's characteristics in the treatment of children and adolescents with psychiatric disorders.

18 Feb 2015

Anticoagulant fondaparinux lowers risk of major bleeding events, death in heart attack patients

Patients who experienced a certain type of heart attack who received the anticoagulant fondaparinux had a lower risk of major bleeding events and death both in the hospital and after six months compared to patients who received low-molecular-weight heparin (LMWH), although both groups had similar rates of subsequent heart attack or stroke, according to a study in the February 17 issue of JAMA.

18 Feb 2015

Researchers identify molecule that can block progression of Alzheimer's disease

A molecule that can block the progress of Alzheimer's disease at a crucial stage in its development has been identified by researchers in a new study, raising the prospect that more such molecules may now be found.

18 Feb 2015

CAMH scientists discover potential new approach to treat multiple sclerosis

Scientists at the Centre for Addiction and Mental Health have discovered a promising new approach to treat multiple sclerosis (MS). In a new study, they've identified a previously unknown change in the spinal cord related to MS, and a way to alter this change to reduce the nerve cell damage that occurs with the disease.

18 Feb 2015

Therapy News and Research

Mirixa integrates with PrescribeWellness

Advances in stem cell therapy can improve outcomes for patients with chronic diabetic foot ulcers

Regulus Therapeutics reports net loss of $22.2 million for fourth quarter 2014

Epic Health Services acquires Loving Care Agency

Scientists identify potential target to combat leishmaniasis

TE Connectivity signs definitive agreement to acquire AdvancedCath

TDF monotherapy ‘reasonable’ option in entecavir-resistant HBV

Long-term TDF ‘promising’ in Chinese HBV patients after multiple antiviral failures

Facts about precision medicine

Caris Life Sciences announces record-setting revenue for 2014

Oncolytics announces completion of patient enrollment in REOLYSIN Phase II colorectal cancer study

Researchers show importance of DNA damage in fine tuning of innate immune system

CTCA presents research on new cancer nutrition therapies at A.S.P.E.N. Clinical Nutrition Week

SLU researchers halt fatty liver disease in animal model

Eliglustat drug improves liver, spleen size and hemoglobin level in adults with Gaucher disease type 1

Postmenopausal women susceptible to bone fractures may be at increased risk for gum disease

Organizational culture may increase use of evidence-based treatments for adolescents with psychiatric disorders

Anticoagulant fondaparinux lowers risk of major bleeding events, death in heart attack patients

Researchers identify molecule that can block progression of Alzheimer's disease

CAMH scientists discover potential new approach to treat multiple sclerosis

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News